Japanese Organization for Medical Device Development
Sanamedi, Inc. is a Tokyo-based privately held firm providing end-to-end medical device development consulting to 50+ client companies, selling its proprietary AVNeo device in 35+ countries, and investing in medtech startups with 16.1 billion JPY deployed across 12 portfolio companies as of 2024.
- Company typePrivate
- Founded2023
- HeadquartersTokyo, Japan
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Japanese Organization for Medical Device Development does
Sanamedi, Inc., formerly the Japanese Organization for Medical Device Development (rebranded April 2023), is a privately held Tokyo-based medical device development and commercialization firm operating across three integrated pillars: consulting, proprietary products, and venture investment. The consulting pillar is the core revenue engine, providing end-to-end support to companies entering or expanding in the medical device market — from upstream regulatory strategy and clinical affairs through downstream commercialization and overseas expansion — with the firm reporting 50+ client companies supported over the recent 2–3 year period across three target segments (new entrants, existing device companies, and academia/startups). The proprietary product pillar is anchored by AVNeo, a medical device co-developed with clinicians and academia that is sold internationally in 35+ countries through distributor channels. The investment pillar deploys capital into startups and academic ventures, with cumulative investments of 16.1 billion JPY across 12 portfolio companies as of 2024, including investee P-Mind Inc. which received the SME Excellent New Technology and New Product Award.
The company's go-to-market is sales-led and consultative, engaging enterprise clients directly with quote-based pricing tailored to project scope, while AVNeo reaches end users through international medical device distributors. Recent strategic activity signals a deliberate expansion of capability and positioning: recruitment of Terumo's former CTO as Sanamedi's CTO (April 2024), selection for a government-funded AI Hospital Implementation project (May 2024), expansion into transdermal pharmaceutical formulation consulting (December 2023), establishment of a Medical Consortium preparation committee (December 2024), and discontinuation of the non-core 3D Back Scanner product (August 2024). The firm also operates a research initiative in medical AI under the Small and Medium Enterprise Innovation Creation Promotion Program. Ownership is described as founder/management-controlled with no disclosed external shareholders, and no funding rounds for Sanamedi itself have been disclosed despite the firm reporting cumulative portfolio investment activity.
Japanese Organization for Medical Device Development firmographics
Firmographics- Name
- Japanese Organization for Medical Device Development
- Legal name
- サナメディ株式会社
- Website
- https://jomdd.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Sanamedi, Inc. is a Tokyo-based privately held firm providing end-to-end medical device development consulting to 50+ client companies, selling its proprietary AVNeo device in 35+ countries, and investing in medtech startups with 16.1 billion JPY deployed across 12 portfolio companies as of 2024.
- Ownership category
- akta.pro rank
Japanese Organization for Medical Device Development industry classification
Industry- Product category
- Medical Device Development Consulting
- NAICS
- Scientific Research and Development Services (5417), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000)
- akta.pro primary industry
- Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)
Keywords
Where Japanese Organization for Medical Device Development is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Markets served
Japanese Organization for Medical Device Development business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others
Revenue model
- Consulting Services: Medical device development consulting services supporting companies entering or expanding in the medical device market. Provides services from upstream development to downstream commercialization and overseas expansion.
- Own Product Sales (AVNeo): Revenue from proprietary medical device product AVNeo, sold in 35+ countries globally.
- Investment Returns: Investment in startups and academic ventures with accumulated investment of 161 billion yen across 12 companies as of 2024, generating returns through equity appreciation.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Japanese Organization for Medical Device Development product offering
Product offeringCore offering
Sanamedi provides medical device development consulting services covering the full lifecycle from upstream development methodology and regulatory affairs to downstream commercialization, market entry, and overseas expansion. The company supports 50+ client companies, distributes its proprietary AVNeo medical device across 35+ countries, and invests in and incubates medical startups and academic ventures with cumulative investments of 16.1 billion JPY across 12 portfolio companies as of 2024.
Product overview
Sanamedi, Inc. (formerly Japanese Organization for Medical Device Development) operates three integrated business pillars: (1) Medical Device Development Consulting — a core service covering the full development lifecycle from upstream regulatory strategy through downstream commercialization and overseas expansion, with 50+ client companies supported; (2) Proprietary Products — most notably AVNeo, a medical device sold across 35 countries in collaboration with clinicians and academia; and (3) Investment & Incubation — identifying, investing in, and supporting startups and academic ventures, with cumulative investments of 12 companies totaling 16.1 billion JPY. The company also runs a government-funded AI Hospital implementation research initiative and has discontinued the 3D Back Scanner product. All three pillars feed into the company's mission of bringing Japanese medical innovation to the world.
Differentiator
Problem solved
Functional benefit
Brands
- AVNeo: Self-developed medical product sold in 35+ countries
Products and services
- AVNeo Proprietary medical device developed by Sanamedi in collaboration with medical professionals and academia, marketed and sold internationally across 35 countries.
- Medical Device Development Consulting Comprehensive consulting covering the full lifecycle of medical device development — from regulatory strategy and clinical affairs to market entry and overseas expansion — supporting over 50 client companies in new business development within the healthcare sector.
- Investment and Startup Incubation Investment and incubation services targeting academia and startup companies, involving identification, investment, and operational support, with cumulative investments of 12 companies totaling 16.1 billion JPY as of 2024.
Quantifiable outcome
- 50+ companies supported through consulting
- +1 more outcomes
Companies that use Japanese Organization for Medical Device Development
Customer profileSegments3 records
Ideal customer profiles3 records
Japanese Organization for Medical Device Development technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature1 record
Japanese Organization for Medical Device Development partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Japan's Agency for Medical Research and Development (AMED)coreBilateral cooperation between Japan's AMED and India's Indian Council of Medical Research on medical research and medical device development. Part of broader India-Japan strategic partnership in science and technology.
- India's Department of Science and Technology (DST)coreCooperation with Japan's Cabinet Office and India's DST covering quantum science including computing, communication, sensing, and materials research. Builds on Prime Minister Modi visit to Japan in 2025.
- Japan's Cabinet OfficecoreJoint quantum science cooperation between Japan's Cabinet Office and India's DST covering computing, communication, sensing, and materials research as part of Indo-Pacific innovation partnership.
- Medical Consortium (Preparation Committee)coreEstablished preparation committee in December 2024 to create a Medical Consortium for medical innovation ecosystem development. Represents collaborative industry initiative.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Japanese Organization for Medical Device Development competitors and assessment
Company assessmentDirect peers
- NAMSA: NAMSA is a global medical device-focused consulting, testing, and regulatory services firm. It is directly comparable to Sanamed because both provide end-to-end medical device development support including regulatory affairs, quality compliance, and commercialization services to device manufacturers.
- RQM+: RQM+ is a medical device regulatory and quality consulting firm serving manufacturers with FDA, CE marking, and international market access support. Directly comparable to Sanamed's core regulatory affairs and quality engineering consulting services for medical device clients.
- Biomerics: Biomerics is a medical device contract development and manufacturing organization (CDMO) specializing in interventional, surgical, and cardiac devices. Comparable to Sanamed because it combines design/development services with proprietary device manufacturing, mirroring Sanamed's consulting-plus-AVNeo model.
Broad incumbents
- Integer Holdings: Integer Holdings is a large publicly-traded medical device CDMO offering design, manufacturing, and regulatory services globally. Comparable as a much larger incumbent in the medical device development services space where Sanamed competes, though Integer's scale and breadth far exceed Sanamed's.
- CMIC Group: CMIC Group is Japan's largest CRO/CDMO with established medical device and pharmaceutical development services. Comparable as a Japan-based incumbent offering medical device consulting and commercialization support, though it operates across broader therapeutic areas and at significantly larger scale.
- Edwards Lifesciences: Edwards Lifesciences is the global leader in heart valve therapies and structural heart disease treatments. Directly relevant as a benchmark for AVNeo's cardiovascular device category, though operating at vastly larger scale as a focused incumbent.
- Terumo Corporation: Terumo is a leading Japanese medical device company with deep cardiovascular and hospital products expertise. Directly comparable as a Japan-based cardiovascular device incumbent; Sanamed's CTO was recruited from Terumo, reflecting the close sector relationship and shared specialty focus.
- Artivion: Artivion (formerly CryoLife) is a cardiac and vascular surgery medical device company offering tissue and mechanical heart valve products. Comparable as an incumbent in the cardiac surgical device space where AVNeo competes.
- WuXi AppTec: WuXi AppTec is a global CRO/CDMO providing medical device testing, regulatory affairs, and development services across multiple regions. Comparable as a much larger incumbent offering medical device development services at global scale.
- Eurofins Medical Device Testing: Eurofins Medical Device Testing provides testing, regulatory, and quality compliance services for medical device manufacturers globally. Comparable as an incumbent offering medical device regulatory and quality services that overlap with Sanamed's consulting offering.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Japanese Organization for Medical Device Development social profiles
Digital presenceJapanese Organization for Medical Device Development financial estimates
Financial estimateRevenue estimate
Valuation estimate
Japanese Organization for Medical Device Development leadership team
Management profileNumber of profiles
Profiles4 records
Japanese Organization for Medical Device Development funding detail
Funding detailFunding overview
Funding rounds6 records
Investors17 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Japanese Organization for Medical Device Development M&A and investment
M&A and investmentM&A
Investments6 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Japanese Organization for Medical Device Development
What does Japanese Organization for Medical Device Development do?
Sanamedi provides medical device development consulting services covering the full lifecycle from upstream development methodology and regulatory affairs to downstream commercialization, market entry, and overseas expansion. The company supports 50+ client companies, distributes its proprietary AVNeo medical device across 35+ countries, and invests in and incubates medical startups and academic ventures with cumulative investments of 16.1 billion JPY across 12 portfolio companies as of 2024.
Is Japanese Organization for Medical Device Development a public or private company?
Japanese Organization for Medical Device Development is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Japanese Organization for Medical Device Development founded?
Japanese Organization for Medical Device Development was founded in 2023. It employs 11 to 50 people.
Where is Japanese Organization for Medical Device Development based?
Japanese Organization for Medical Device Development is headquartered in Tokyo, Japan, in the Asia region.
How does Japanese Organization for Medical Device Development make money?
Three revenue lines are on record. Consulting Services are the primary driver. The others are own Product Sales (AVNeo) and investment Returns.
Who are Japanese Organization for Medical Device Development's main competitors?
Direct peers on record are NAMSA, RQM+ and Biomerics. Broad incumbents are Integer Holdings, CMIC Group, Edwards Lifesciences, Terumo Corporation, Artivion, WuXi AppTec and Eurofins Medical Device Testing.
Does Japanese Organization for Medical Device Development have an API?
No public API is recorded for Japanese Organization for Medical Device Development.
What industry is Japanese Organization for Medical Device Development in?
Japanese Organization for Medical Device Development's product category is Medical Device Development Consulting. Its primary akta.pro industry code is HLAGAKAL, Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control). Its NAICS code is 5417 and its SIC code is 3841.